Sarita, Benjie R.
HRN: 25-75-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
CEFTRIAXONE 1G (VIAL)
02/02/2026
02/09/2026
IV
2g
OD
Mangled Wound
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes